We use cookies to understand how visitors search for and consume the information we provide, so that we can improve their experience. By browsing this website, you indicate your acceptance of the use of such cookiesAcceptRead more

Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Our products& pipeline
    • Diseases we target
    • GS010 for LHON
    • GS030 for Retinitis Pigmentosa
    • GS030 for Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
  • Investors& media
    • Company Overview
    • Press releases
    • Events & presentations
    • News and press coverage
    • Stock information
    • Governance
    • Documentation

Documentation

  • Home >
  • Investors & media >
  • Documentation
30 April 2020
General meetings

Compensation policy of the Board members Open in new window

30 April 2020
General meetings

Compensation policy of the Chief Executive Officer and / or any other Corporate Officer Open in new window

30 April 2020
General meetings

Compensation policy of the Chairman of the Board of Directors Open in new window

30 April 2020
General meetings

Results of the votes of the 2020 General Meeting Open in new window

15 April 2020
General meetings

Convening Notice – 2020 General Meeting Open in new window

08 April 2020
General meetings

Notice of General Meeting on April 29, 2020 Open in new window

08 April 2020
General meetings

Auditor’s report on 2019 Consolidated Financial Statements in accordance with IFRS Open in new window

08 April 2020
General meetings

Auditor’s report on 2019 Financial Statements in accordance with French Gaap Open in new window

08 April 2020
General meetings

Auditor’s report on 2019 related party agreements Open in new window

08 April 2020
General meetings

Auditor’s report on resolution number 24 Open in new window

  • View previous 9 articles
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 11
  • View next 9 articles
© 2021 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
Go back to the page of the page